Identification of new bradyzoite surface antigens for use in toxoplasma gondii vaccines and diagnostics

Projektinformationen

ANNA BRILLOWSKA-DABR

ID Finanzhilfevereinbarung: QLK2-CT-2001-50970

Projekt abgeschlossen

Startdatum 1 Januar 2002

Enddatum 31 Dezember 2003

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 144 352,00

EU-Beitrag € 144 352,00

Koordiniert durch

STATENS SERUM INSTITUT
Denmark

Ziel

In order to select new potentially vaccine genes from T. goodie, Expressed Sequence Tags (EST) database will be search and the gene fragment meets the criteria, further will be full length sequenced and then characterized

Wissenschaftliches Gebiet

• natural sciences › computer and information sciences › databases
• medical and health sciences › basic medicine › pharmacology and pharmacy › pharmaceutical drugs › vaccines

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

STATENS SERUM INSTITUT

• EU-Beitrag: Keine Daten
• Adresse: 5,Artillerivej 5 ; 2300 KOEPENHAGEN ; Dänemark
• Gesamtkosten: Keine Daten